早产儿促红细胞生成素神经保护试验现代队列中极早产儿的死亡情况
该回顾性队列纳入2013年12月13日至2016年9月26日在美国19个中心30个新生儿重症监护病房入组的941例胎龄24 0/7至27 6/7周极早产儿,分析院内死亡的危险因素、直接原因、时间与情形。108例(11%)出院前死亡,主要死因为呼吸窘迫或衰竭、肺出血、坏死性小肠结肠炎、灾难性颅内出血、脓毒症和不明原因猝死,50%死亡发生在生后10天内。死亡风险随日龄和矫正胎龄下降,24周出生且存活14天者与27周出生者死亡条件风险相近(0.08 vs 0.06)。作者认为该信息可能有助于向家庭咨询生存预后。
要点
- 941例极早产儿中108例(11%)出院前死亡,38%(n=41)为24周、30%(n=32)为25周、19%(n=20)为26周、14%(n=15)为27周出生。
- 50%的死亡发生在生后10天内,死亡风险随日龄和矫正胎龄下降。
- 24周出生且存活14天的婴儿与27周出生婴儿死亡条件风险相近:0.08(95%CI 0.03-0.13)vs 0.06(95%CI 0.01-0.11)。
- 严重坏死性小肠结肠炎(HR 7.41)、肺出血(HR 10.0)、严重颅内出血(HR 4.60)、严重脓毒症(HR 4.93)与死亡风险升高相关。
- 51%的婴儿死亡前接受舒适照护。
适用人群与场景
- 2013年12月13日至2016年9月26日在美国19个中心30个新生儿重症监护病房入组、胎龄24 0/7至27 6/7周的极早产儿941例。
- 为早产儿促红细胞生成素神经保护试验入组婴儿的回顾性队列。
研究设计与关键结果
- 研究类型为回顾性队列,纳入941例胎龄24 0/7至27 6/7周极早产儿,来自美国19个中心30个新生儿重症监护病房。
- 108例(11%)出院前死亡:24周38%(n=41)、25周30%(n=32)、26周19%(n=20)、27周14%(n=15);另有9例(1%)出院后死亡。
- 主要死因按降序为呼吸窘迫或衰竭、肺出血、坏死性小肠结肠炎、灾难性颅内出血、脓毒症和不明原因猝死。
- 50%的死亡发生在生后10天内。
- 死亡风险随日龄和矫正胎龄下降:24周出生且存活14天者与27周出生者死亡条件风险分别为0.08(95%CI 0.03-0.13)和0.06(95%CI 0.01-0.11)。
- 早产临产与死亡风险降低相关(HR 0.45;95%CI 0.31-0.66)。
- 与死亡相关的临床因素:出生体重低于同胎龄第10百分位(HR 2.11;95%CI 1.38-3.22)、5分钟Apgar评分低于5分(HR 2.19;95%CI 1.48-3.24)、出生时病态外观(HR 2.49;95%CI 1.69-3.67)、2b-3期坏死性小肠结肠炎(HR 7.41;95%CI 5.14-10.7)、肺出血(HR 10.0;95%CI 6.76-18.8)、严重颅内出血(HR 4.60;95%CI 3.24-5.63)、严重脓毒症(HR 4.93;95%CI 3.67-7.21)。
- 51%的婴儿死亡前接受舒适照护。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该信息可能有助于向家庭咨询生存预后。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Understanding why and how extremely preterm infants die is important for practitioners caring for these infants.
OBJECTIVE: To examine risk factors, causes, timing, and circumstances of death in a modern cohort of extremely preterm infants.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort review of infants enrolled in the Preterm Erythropoietin Neuroprotection Trial between December 13, 2013, and September 26, 2016, was conducted. A total of 941 infants born between 24 0/7 and 27 6/7 weeks of gestation enrolled at 19 US sites comprising 30 neonatal intensive care units were included. Data analysis was performed from October 16, 2020, to December 1, 2021.
MAIN OUTCOMES AND MEASURES: Risk factors, proximal causes, timing, and circumstances of in-hospital death.
RESULTS: Of the 941 enrolled infants, 108 died (11%) before hospital discharge: 38% (n = 41) at 24 weeks' gestation, 30% (n = 32) at 25 weeks' gestation, 19% (n = 20) at 26 weeks' gestation, and 14% (n = 15) at 27 weeks' gestation. An additional 9 infants (1%) died following hospital discharge. In descending order, the primary causes of death included respiratory distress or failure, pulmonary hemorrhage, necrotizing enterocolitis, catastrophic intracranial hemorrhage, sepsis, and sudden unexplained death. Fifty percent of deaths occurred within the first 10 days after birth. The risk of death decreased with day of life and postmenstrual age such that an infant born at 24 weeks' gestation who survived 14 days had the same risk of death as an infant born at 27 weeks' gestation: conditional proportional risk of death, 0.08 (95% CI, 0.03-0.13) vs 0.06 (95% CI, 0.01-0.11). Preterm labor was associated with a decreased hazard of death (hazard ratio [HR], 0.45; 95% CI, 0.31-0.66). Infant clinical factors associated with death included birth weight below the tenth percentile for gestational age (HR, 2.11; 95% CI, 1.38-3.22), Apgar score less than 5 at 5 minutes (HR, 2.19; 95% CI, 1.48-3.24), sick appearance at birth (HR, 2.49; 95% CI, 1.69-3.67), grade 2b-3 necrotizing enterocolitis (HR, 7.41; 95% CI, 5.14-10.7), pulmonary hemorrhage (HR, 10.0; 95% CI, 6.76-18.8), severe intracranial hemorrhage (HR, 4.60; 95% CI, 3.24-5.63), and severe sepsis (HR, 4.93; 95% CI, 3.67-7.21). Fifty-one percent of the infants received comfort care before death.
CONCLUSIONS AND RELEVANCE: In this cohort study, an association between mortality and gestational age at birth was noted; however, for each week that an infant survived, their risk of subsequent death approximated the risk observed in infants born 1 to 2 weeks later, suggesting the importance of an infant's postmenstrual age. This information may be useful to include in counseling of families regarding prognosis of survival.
参考来源
- Juul SE, Wood TR, Comstock BA, et al. Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial. JAMA Netw Open. 2022. PMID: 35129596. doi:10.1001/jamanetworkopen.2021.46404
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。